Movement Alert|Centene Falls 10.89% in Regular Trading, CEO Warns Membership to Miss Targets as Severance Costs Weigh

Market Focus
Jul 28

On July 28, Centene declined 10.89% in regular trading, trading at approximately $58.35/share, with turnover of $158 million. The sharp reversal came despite the company reporting a strong Q2 earnings beat earlier in the session.

On the news front, Centene's CEO disclosed during an earnings call that the company expects year-end membership to fall below previously set targets for the second half, signaling a slowdown in health-plan enrollment growth that could weigh on full-year results. Additionally, the company announced acceptance of applications for a voluntary separation plan, estimated to generate $315 million to $365 million in severance charges. The combined impact of membership headwinds and restructuring costs triggered heavy selling pressure.

Notably, Centene had initially surged over 6% in pre-market trading after reporting Q2 adjusted EPS of $2.51, far exceeding the $1.08 consensus estimate, with revenue of $53.58 billion also beating the $47.62 billion forecast. Management also guided full-year adjusted EPS above $4.80 versus the FactSet estimate of $3.51. However, the membership warning and severance disclosure during the call overwhelmed the positive earnings surprise.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10